These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 3110436)

  • 1. Acute nonlymphocytic leukemia after thiotepa instillation into the bladder: report of 2 cases and review of the literature.
    Silberberg JM; Zarrabi MH
    J Urol; 1987 Aug; 138(2):402-3. PubMed ID: 3110436
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intractable bladder hemorrhage requiring cystectomy after use of intravesical thiotepa.
    Treible DP; Skinner D; Kasimain D; Friedman NB; Kern WH
    Urology; 1987 Dec; 30(6):568-70. PubMed ID: 3120389
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute nonlymphocytic leukemia following bladder instillations with thiotepa.
    Easton DJ; Poon MA
    Can Med Assoc J; 1983 Sep; 129(6):578-9. PubMed ID: 6411320
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effects of intravesical instillation of antitumor agents on bladder cancer].
    Tomiyama T
    Nihon Hinyokika Gakkai Zasshi; 1972 Jul; 63(7):497-518. PubMed ID: 4628074
    [No Abstract]   [Full Text] [Related]  

  • 5. Generalized hypersensitivity reaction to intravesical thiotepa and doxorubicin.
    Lee M; Sharifi R
    J Urol; 1987 Jul; 138(1):143-4. PubMed ID: 3110433
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nephrogenic adenoma in patients with transitional cell carcinoma of the bladder receiving intravesical thiotepa.
    Wood DP; Streem SB; Levin HS
    J Urol; 1988 Jan; 139(1):130-1. PubMed ID: 3121867
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intravesical thiotepa in the treatment of transitional cell bladder carcinoma.
    Mitchell RJ
    Br J Urol; 1971 Apr; 43(2):185-8. PubMed ID: 4996214
    [No Abstract]   [Full Text] [Related]  

  • 8. The effect of intravesical thiotepa on the recurrence rate of newly diagnosed superficial bladder cancer. An MRC Study. MRC Working Party on Urological Cancer.
    Br J Urol; 1985 Dec; 57(6):680-5. PubMed ID: 2867800
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term intravesical thiotepa treatment in patients with superficial bladder tumors and vesicoureteral reflux.
    Nissenkorn I; Servadio C; Vilikowski E; Glanz I
    J Urol; 1985 Feb; 133(2):198-9. PubMed ID: 3918177
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The harmfulness of intravesical instillations of thiotepa in cases of vesico-renal reflux].
    Rampal M; Alimi JC; Pons G; Fiquet JM
    J Urol Nephrol (Paris); 1978 Mar; 84(3):271-4. PubMed ID: 417193
    [No Abstract]   [Full Text] [Related]  

  • 11. Nephrogenic adenoma in a patient with chronic renal failure associated with intravesical treatment with thiotepa.
    Embon OM; Turani H; Gold CH; Sazbon A
    Eur Urol; 1990; 17(2):181-2. PubMed ID: 2107082
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bacillus Calmette-Guerin versus doxorubicin versus thiotepa: a randomized prospective study in 202 patients with superficial bladder cancer.
    Martínez-Piñeiro JA; Jiménez León J; Martínez-Piñeiro L; Fiter L; Mosteiro JA; Navarro J; García Matres MJ; Cárcamo P
    J Urol; 1990 Mar; 143(3):502-6. PubMed ID: 2106041
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors influencing the absorption of antineoplastic agents in intravesical instillation treatment of bladder tumors. An experimental and clinical study.
    Gu FL; Shi T; Feng T; Wu JP
    Chin Med J (Engl); 1987 Feb; 100(2):127-31. PubMed ID: 3109841
    [No Abstract]   [Full Text] [Related]  

  • 14. Early onset life-threatening myelosuppression after low dose of intravesical thiotepa.
    Agnelli G; de Cunto M; Gresele P; del Favero A
    Postgrad Med J; 1982 Jun; 58(680):380-1. PubMed ID: 6812036
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ThioTEPA pharmacokinetics during intravesical chemotherapy and the influence of Tween 80.
    Masters JR; McDermott BJ; Jenkins WE; Fenwick E; Shah PJ; Mundy AR; Loadman PM; Bibby MC
    Cancer Chemother Pharmacol; 1990; 25(4):267-73. PubMed ID: 1688515
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The expression of p53 and bcl-2 in superficial bladder transitional cell carcinoma and its role in the outcome of postoperative intravesical chemotherapy.
    Tzai TS; Chow NH; Lin JS; Yang WH; Tong YC
    Anticancer Res; 1998; 18(6B):4717-21. PubMed ID: 9891547
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intravesical chemotherapy for superficial carcinoma of the bladder.
    Foo KT; Tan EC; Tung KH; Tock EP
    Singapore Med J; 1991 Dec; 32(6):420-2. PubMed ID: 1788600
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sterilisation following instillation of thiotepa into the urinary bladder.
    Homonnai TZ; Paz G; Servadio C
    Br J Urol; 1982 Feb; 54(1):60. PubMed ID: 6800432
    [No Abstract]   [Full Text] [Related]  

  • 19. Transitional cell carcinoma of the prostate following intravesical therapy for transitional cell carcinoma of the bladder.
    Hardeman SW; Perry A; Soloway MS
    J Urol; 1988 Aug; 140(2):289-92. PubMed ID: 3135420
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemotherapy in superficial neoplasms of the bladder.
    Zingg E; Sulmoni A
    S Afr Med J; 1972 Jul; 46(27):916-7. PubMed ID: 4626807
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.